NCT05389852View on ClinicalTrials.gov

Analgesic Efficacy of Intravenous Dexmedetomidine for Supraclavicular Plexus Block

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

February 7, 2024

Study Completion Date

February 7, 2024

Conditions
Surgery
Interventions
DRUG

Dexmedetomidine

After completion of supraclavicular brachial plexus block patients will receive intravenous dexmedetomidine 1 mcg/kg

Trial Locations (1)

1950

Hopital du Valais, Sion

All Listed Sponsors
lead

Hôpital du Valais

OTHER